JPRN-UMIN000045264已完成未知
Preliminary investigation of concerning human immune parameters. - Preliminary investigation of concerning human immune parameters.
CPCC Company Limited0 个研究点目标入组 66 人开始时间: 2021年8月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 66
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 79years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1)Subjects who are regularly consuming food for specified health uses (FOSHU), food with function claims, supplement and/or health foods which would affect the study results for more than 3 days a week. (2)Subjects who have a plan or who have taken medication (e.g., antibiotics, steroids, antihistamines), which would affects the study results. (3)Subjects who take excessive alcohol. (4)Subjects who are participating or have participated in another clinical study with medicine/food within the last 4 weeks before this study, or are planning to join those after giving informed consent. (5)Subjects who will be vaccinated with various vaccines during the month leading up to the test-1 and during the test period (e.g., those who are waiting for an appointment or standby for coronavirus vaccination). (6)Subjects who have current medical history/anamnesis of severe cardiac, hepatic, renal or digestive diseases. (7)Subjects who are pregnant, lactating, or intend to become pregnant during the study period. (8)Subjects who are allergic to drugs or foods. (9-11)Subjects who have been donated their blood components and/or whole blood prior to the pre-inspection as follows: - males/females: 200 mL of blood components within a month - males: 400 mL of whole blood within the last 3 months - females: 400 mL of whole blood within the last 4 months. (12-13)Subjects who have been donated their blood within the last 12 months, which would reaches to the following volume after adding their blood amount planning to be collected in this study; - males: 1,200 mL - females: 800 mL (14)Subjects with systolic blood pressure of 180 mmHg or higher, and/or diastolic blood pressure of 110 mmHg or higher. (15) Others who have been determined ineligible by principal/sub investigator.
研究者
相似试验
招募中
2 期
Exploratory study evaluating the potential of immune signature profiling for predicting response in patients with resectable Stage II, IIIA and select IIIB (T3N2 only) non-squamous Non-Small Cell Lung Cancer (NSCLC) to neoadjuvant ATEZOLIZUMAB plus Carboplatin/Nab PaclitaxelLung cancer2024-516590-75-00Universitaetsklinikum Heidelberg AöR, Universitaetsklinikum Heidelberg AöR20
已完成
Unknown
A study for evaluating the immune response by ingestion of fermented plant extractHealthy adultJPRN-UMIN000052021EP Mediate Co., Ltd.36
已完成
不适用
A study for evaluating the immune response by ingestion of a fucoidan-containing food in adult males and females : a randomized, double blind, placebo-controlled, parallel-group trialJPRN-UMIN000024995TTC Co., Ltd.60
招募中
不适用
The study investigating the immuno-pathogenesis in myasthenia gravis using peripheral blood and resected thymus tissueMyasthenia gravisJPRN-UMIN000045475Graduate School of Medicine, Chiba University100
招募中
不适用
Analysis of the immunological conditions in the intestinal mucosa of inflammatory bowel diseaseJPRN-UMIN000039795Internal Medicine (gastroenterlogy) Tokai University School of Medicine100